Disc Medicine, Inc. (IRON) Cash Flow Statement
Disc Medicine, Inc. (IRON) generated -$197.5M of operating cash flow over the twelve months to 2026-06-30, spent $46000 on capital expenditure and had free cash flow of -$197.6M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IRONDisc Medicine, Inc.Follow IRON — free
—
Price chart with a free account
- Market cap
- 2.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -27.5 | -42.3 | -73.5 | -93.9 | -180.4 | -197.5 | |
| Capital expenditure | 0.1 | 0.2 | 0.1 | 0.5 | 0.9 | -0.0 | |
| Free cash flow | -27.6 | -42.4 | -73.6 | -94.4 | -181.3 | -197.6 | |
| Dividends paid | 0.0 | — | — | — | — | — | |
| Stock-based compensation | 0.5 | 2.1 | 5.5 | 16.8 | 34.3 | — |
USD millions · SEC XBRL
Disc Medicine, Inc. — questions
- What is Disc Medicine, Inc.'s operating cash flow?
- -$197.5M over the twelve months to 2026-06-30.
- How much does Disc Medicine, Inc. spend on capital expenditure?
- $46000 over the twelve months to 2026-06-30.
- What is Disc Medicine, Inc.'s free cash flow?
- -$197.6M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Disc Medicine, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.